Cencora (COR) Stock Forecast

NYSE: CORAnalyst ratings, price target and estimates.

COR analyst forecast

as of October 17, 2026
Analyst consensus
Buy
4.21 / 5 from 14 analysts
Price target
$367.67
average of analyst targets
Upside to target
+7.8%
from the latest close
Next earnings
November 4, 2026
EPS estimate $4.54
52-week range
$252.74 – $374.75

COR analyst ratings

14 analysts
Strong buy
750%
Buy
321%
Hold
429%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

COR price target

Price $340.92Target $367.67
52-week low $252.7452-week high $374.75

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

COR earnings per share estimates

Cencora EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Next quarter (Dec '26)$4.60$4.46$4.99$4.08+12.8%7
Current fiscal year (FY2026)$17.88$17.80$17.93$16.00+11.7%14
Next fiscal year (FY2027)$19.75$19.44$20.08$17.88+10.5%9

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

COR revenue estimates

Cencora revenue estimates
PeriodAverageLowHighGrowthAnalysts
Next quarter (Dec '26)$89.88B$89.12B$90.60B+4.6%4
Current fiscal year (FY2026)$337.03B$335.74B$337.77B+4.9%12
Next fiscal year (FY2027)$351.68B$344.78B$356.80B+4.3%7

COR EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

COR revenue: reported and forecast

Reported revenueEstimate (average; low–high)

COR EPS estimate revisions

Cencora EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Next quarter (Dec '26)$4.51$4.54$4.59$4.60$4.60+2.1%1 up · 2 down
Current fiscal year (FY2026)$17.78$17.87$17.87$17.88$17.88+0.6%10 up · 0 down
Next fiscal year (FY2027)$19.81$19.81$19.81$19.80$19.75−0.3%1 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

COR earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; COR beat in 12 of 12.

What analysts expect from COR

14 analysts cover Cencora; their consensus rating is buy (4.21 on a 1–5 scale, where 5 is a strong buy). The average price target is $367.67, 7.8% above the latest close of $340.92. Analysts expect earnings of $17.88 per share for FY2026, +11.7% from a year earlier. For FY2027 the average estimate is $19.75 per share on revenue of $351.7 billion. Cencora beat the EPS estimate in 12 of the last 12 quarters.

Related: COR income statement, COR key metrics, COR chart. See the COR stock overview for the latest quote and news.

COR forecast FAQ

What is Cencora's price target?

The average analyst price target for Cencora is $367.67, 7.8% above the latest close of $340.92.

Is Cencora a buy, hold or sell?

Of 14 analysts covering Cencora, 7 rate it a strong buy, 3 a buy, 4 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Cencora's EPS forecast?

Analysts forecast $17.88 per share for FY2026 (range $17.80 to $17.93); for FY2027 the estimate is $19.75.

What is Cencora's revenue forecast?

The average revenue estimate for FY2026 is $337.0 billion, growth of 4.9%; for FY2027 it is $351.7 billion.

When does Cencora report earnings?

Cencora is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $4.54.

Does Cencora usually beat earnings estimates?

Cencora reported EPS at or above the analyst estimate in 12 of the last 12 quarters.

Medical Distribution: forecast